- Home
- SNSE vs KXIN Comparison
SNSE vs KXIN Comparison
Compare SNSE & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- KXIN
- Stock Information
- Founded
- SNSE 2005
- KXIN 2015
- Country
- SNSE United States
- KXIN China
- Employees
- SNSE N/A
- KXIN N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- SNSE Health Care
- KXIN Consumer Discretionary
- Exchange
- SNSE Nasdaq
- KXIN Nasdaq
- Market Cap
- SNSE 10.2M
- KXIN 7.0M
- IPO Year
- SNSE 2021
- KXIN N/A
- Fundamental
- Price
- SNSE $8.81
- KXIN $0.60
- Analyst Decision
- SNSE Strong Buy
- KXIN
- Analyst Count
- SNSE 4
- KXIN 0
- Target Price
- SNSE $72.50
- KXIN N/A
- AVG Volume (30 Days)
- SNSE 16.6K
- KXIN 205.0K
- Earning Date
- SNSE 08-05-2025
- KXIN 01-01-0001
- Dividend Yield
- SNSE N/A
- KXIN N/A
- EPS Growth
- SNSE N/A
- KXIN N/A
- EPS
- SNSE N/A
- KXIN N/A
- Revenue
- SNSE N/A
- KXIN N/A
- Revenue This Year
- SNSE N/A
- KXIN N/A
- Revenue Next Year
- SNSE N/A
- KXIN N/A
- P/E Ratio
- SNSE N/A
- KXIN N/A
- Revenue Growth
- SNSE N/A
- KXIN N/A
- 52 Week Low
- SNSE $5.00
- KXIN $0.57
- 52 Week High
- SNSE $17.40
- KXIN $29.54
- Technical
- Relative Strength Index (RSI)
- SNSE 58.00
- KXIN 31.30
- Support Level
- SNSE $7.79
- KXIN $0.57
- Resistance Level
- SNSE $8.69
- KXIN $0.71
- Average True Range (ATR)
- SNSE 0.73
- KXIN 0.05
- MACD
- SNSE 0.08
- KXIN -0.01
- Stochastic Oscillator
- SNSE 79.72
- KXIN 14.85
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.